Element Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Element Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$91.83 - $120.68 $4.28 Million - $5.62 Million	-46,580 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $3.76 Million - $5.55 Million	43,876 Added 1622.63%	46,580 $4.7 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $11,061 - $15,943	125 Added 4.85%	2,704 $342,000
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $154,740 - $220,942	2,579 New	2,579 $216,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.